TLDR AbbVie grew 2025 revenue 8.6% to $61.16 billion and raised its dividend 5.5% for 2026, backed by strong drug sales Chevron reported record 2025 productionTLDR AbbVie grew 2025 revenue 8.6% to $61.16 billion and raised its dividend 5.5% for 2026, backed by strong drug sales Chevron reported record 2025 production

Five High-Dividend Stocks That Could Outperform Over the Next 3 Years

2026/04/19 22:07
4분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

TLDR

  • AbbVie grew 2025 revenue 8.6% to $61.16 billion and raised its dividend 5.5% for 2026, backed by strong drug sales
  • Chevron reported record 2025 production and a 158% reserve replacement ratio, with analysts leaning toward Buy
  • Shell generated $26.1 billion in free cash flow in 2025 and is one of the world’s largest LNG operators
  • Enterprise Products Partners yields close to 6% with 1.7x distribution coverage, showing the payout is well supported
  • Realty Income posted Q4 2025 AFFO of $1.08 per share and pays its dividend monthly

Five high-dividend stocks are drawing attention from income investors looking for reliable returns over the next three to five years. The names are AbbVie, Chevron, Shell, Enterprise Products Partners, and Realty Income.

Each yields above 3%, and each has a business case that goes beyond just the dividend. The idea is not to chase the biggest yield. It is to find companies with steady cash flow, manageable debt, and dividends backed by real earnings.


AbbVie

AbbVie is the top-ranked pick in the group. The stock yields around 3.3%, and the company reported 2025 revenue of $61.16 billion, up 8.6% from the prior year.


ABBV Stock Card
AbbVie Inc., ABBV

Drugs like Skyrizi and Rinvoq have helped replace lost sales from Humira, which faced biosimilar competition in recent years. The transition has gone better than many analysts expected.

AbbVie raised its dividend by 5.5% for 2026. On Wall Street, MarketBeat shows 16 buys, 9 holds, and 0 sells, giving it a Moderate Buy rating. No analyst currently has a sell on the stock.


Chevron

Chevron reported record production levels in 2025 and a 158% reserve replacement ratio, meaning it replaced far more oil and gas reserves than it produced during the year.


CVX Stock Card
Chevron Corporation, CVX

It raised its quarterly dividend to $1.78 per share. Analyst sentiment sits at a Hold overall, with 14 buys, 6 holds, and 4 sells on MarketBeat.

The mixed rating could work in investors’ favor. Less enthusiasm from Wall Street often leaves more room for upside if oil prices hold firm and the company keeps returning cash to shareholders.


Shell

Shell is not just an oil company. It is also one of the largest liquefied natural gas operators in the world, which gives it a different profile from most U.S. energy peers.

In 2025, Shell generated $42.9 billion in cash flow from operations and $26.1 billion in free cash flow. The company targets returning 40% to 50% of operating cash flow to shareholders.

MarketBeat lists Shell with 6 buys, 13 holds, and 0 sell ratings. Its LNG business adds a layer of exposure that pure oil majors do not offer.


Enterprise Products Partners

Enterprise Products Partners offers the highest yield in the group at close to 6%. The partnership reported distribution coverage of 1.7x in its latest results, meaning cash flow comfortably covers the payout.

That coverage ratio matters. A yield near 6% can look like a warning sign, but strong coverage suggests the dividend is not under pressure.

MarketBeat shows a Moderate Buy consensus with 10 buys, 6 holds, and 2 sells. Investors who take a position will receive a K-1 tax form, which is standard for master limited partnerships.


Realty Income

Realty Income is known as “The Monthly Dividend Company” and pays shareholders every month. It reported Q4 2025 adjusted funds from operations of $1.08 per share, with net debt to EBITDAre at 5.4x.

The stock is rate-sensitive, meaning its performance tends to track interest rate moves closely. If rates fall over the next few years, Realty Income could benefit from both its yield and a rise in its valuation.

Analyst sentiment is cautious, with 6 buys, 9 holds, and 1 sell on MarketBeat and a broader Hold consensus on StockAnalysis.

Final Thoughts

Across all five names, AbbVie ranks first for its blend of income and earnings growth. Chevron and Shell offer energy exposure with strong cash returns. Enterprise Products ranks fourth for high current income, and Realty Income fifth for monthly dividends and potential rate-driven upside.

The post Five High-Dividend Stocks That Could Outperform Over the Next 3 Years appeared first on CoinCentral.

시장 기회
MyShell Token 로고
MyShell Token 가격(SHELL)
$0.0339
$0.0339$0.0339
+0.35%
USD
MyShell Token (SHELL) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!